Propafenone efficacy in paroxysmal atrial fibrillation
Efficacy and safety of class IС antiarrhythmic agent, propafenone, was investigated in patients with paroxysmal atrial fibrillation (PAF), after single-dose load and during long-term preventive treatment. The study included 20 male and female patients (mean age 53,8+2,4 years). PAF was caused by cor...
| الحاوية / القاعدة: | Российский кардиологический журнал |
|---|---|
| المؤلفون الرئيسيون: | , , , , |
| التنسيق: | مقال |
| اللغة: | الروسية |
| منشور في: |
«FIRMA «SILICEA» LLC
2004-12-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://russjcardiol.elpub.ru/jour/article/view/2328 |